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Abstract
Background and objectives This study was conducted to
measure the level of health-related quality of life (HRQOL)
and to reveal the association of self-efficacy and treatment
satisfaction with it in Korean dialysis patients.
Design, setting, participants, and measurements The
study subjects were 237 patients receiving either hemodi-
alysis (HD) or peritoneal dialysis (PD) from two university
hospitals, from February to June in 2010. We investigated
HRQOL using the Korean version of Kidney Disease
Quality of Life Short Form 36 (KDQOL-36), and self-
efficacy and treatment satisfaction by self-administrative
questionnaire and their dialysis-related variables by
reviewing clinical records. The associations of self-efficacy
and treatment satisfaction with HRQOL were assessed
using multiple linear regression analysis.
Results The mean HRQOL results were as follows:
Physical component score (PCS) was 39.1 ± 8.5, Mental
component score (MCS) 44.6 ± 6.8, symptom/problem list
was 67.6 ± 17.1, effects of disease score was 58.5 ± 19.6,
and burden of disease score was 41.1 ± 28.4. Between PD
and HD patients, we could find significant difference only
in the symptom/problem list. After removing confounder’s
effects by multivariate analysis, respectively, treatment
goal self-efficacy and treatment management self-efficacy
were significantly related with all 5 domains, except PCS.
Treatment satisfaction was significantly related with PCS,
MCS, and effects of kidney disease.
Conclusions Patients’ self-efficacy and treatment satis-
faction could influence their HRQOL. Regular and sys-
tematic monitoring using KDQOL-36 and interventions to
increase self-efficacy and treatment satisfaction should be
considered in dialysis care in Korea.
Keywords ESRD  Quality of life  Self-efficacy 
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Introduction
In the recent decades, health-related quality of life
(HRQOL) has been widely accepted as a valid marker of
both treatment outcome and mortality for patients with
chronic diseases [1, 2]. It is also considered as a consistent
and powerful predictor of health outcomes in end stage
renal disease (ESRD) [3–9]. It is generally agreed that
HRQOL of dialysis patients is usually poorer than that of
the age-matched subjects from the general population,
because of the typically high burden of comorbidity and
complications of ESRD [3].
Recently, there has been increasing interest in factors
impacting on HRQOL of ESRD patients, but it has not
been clearly confirmed yet which of them showed the
strongest influence on the patients’ HRQOL [9–13].
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Generally, ESRD patients are in great need for self-man-
agement of long-term illnesses and must frequently make
daily decisions involving fluid intake, nutrition, physical
activity, and symptom management [13–15]. Additionally,
self-efficacy and treatment satisfaction are known to
influence these self-management and decision-making
processes [16–18]. Until now, several previous studies
have dealt with self-efficacy [19–22] and treatment satis-
faction [23, 24], but most of them used SF-36 and showed
limitation in considering disease-specific HRQOL.
Therefore, the purpose of this study was to measure the
level of HRQOL using KDQOL-36 and to reveal the
association of self-efficacy and treatment satisfaction with
HRQOL in Korean patients with ESRD.
Subjects and methods
Subjects
The prevalent dialysis patients, including both hemodial-
ysis (HD) and peritoneal dialysis (PD) patients from two
university hospitals, had been included from February to
June in 2010. Patients who were on the dialysis for acute
kidney injury were excluded from the study. The Institu-
tional Review Board of Kyungpook National University
Hospital approved the research protocol [IRB Number:
KNUH_09_1045]. All subjects gave written informed
consent before study enrollment.
Instruments
We investigated the socio-demographic factors, treatment
satisfaction, self-efficacy and HRQOL by self-administra-
tive questionnaire and dialysis-related factors by reviewing
the clinical records.
Self-efficacy was composed of 11-items with 2 sub-
scales (i.e., 7 items for treatment goal self-efficacy and 4
items for treatment management self-efficacy). The items
were modified from those referring to empowerment of
diabetes patients [18]. Responses were on 5-point Likert
scales; we used mean scores (range: 1–5). The modified
scale used in this study demonstrated adequate content
validity and internal consistency reliability (Cronbach’s
alpha = 0.90 and 0.86, respectively). Construct validity
was supported by factor analysis, and the result was that
self-efficacy was composed of two subscales.
The 10-item questionnaire asked about treatment satis-
faction during dialysis. Responses were on a 7-point Likert
scale where 0—strongly disagree and 6—strongly agree.
Scores were summed and ranged from 0 to 60. In this
study, the internal consistency coefficient (Cronbach’s
alpha) was 0.88 and factor analysis resulted in all items
loading greater than 0.42 on a single factor.
The Korean version of the KDQOL-36 includes 12
items that provide a generic chronic disease core (i.e., the
SF-12, a shorter version of the SF-36), as well as 24
additional items (i.e., kidney-disease-targeted items). The
24 additional items focus on particular health-related
concerns of individuals with kidney disease (i.e., symptom/
problem list, 12 items; effects of kidney disease, 8 items;
and burden of disease, 4 items). The item scores were
aggregated without weighting and transformed linearly to a
0–100 possible range, with higher scores indicating better
states, which resulted in a total of dimensions.
Statistical analysis
To compare scores of HRQOL subscales by socio-demo-
graphic and disease-related factors, the Student’s t test and
analysis of variance were used. The associations of self-
efficacy and treatment satisfaction with HRQOL subscales
were assessed using Pearson correlation coefficients. To
assess these associations after adjusting for possible con-
founders, multiple linear regression analyses were per-
formed. Selected confounders were age, sex, educational
level, job, dialysis method, dialysis duration, causes of
ESRD, dialysis adequacy, comorbidity, and serum albumin
level. The SPSS 15.0 statistical package for Windows
(SPSS, Chicago, IL) was used for all statistical analyses.
Results
A total of 237 patients were recruited in this study,
including 172 (72.6 %) HD patients and 65 (27.4 %) PD
patients.
Their socio-demographic and disease-specific charac-
teristics are shown in Tables 1 and 2, respectively. Overall,
54.0 % were male, 27.8 % younger than 49 years, 24.9 %
50–59 years, 26.2 % 60–69 years, and 21.1 % older than
70 years. In the disease-specific characteristics, 61.0 %
received dialysis treatment for more than 2 years and dia-
betes mellitus was the most common (39.7 %) cause of
ESRD, followed by hypertension (29.1 %) and glomeru-
lonephritis (10.5 %).
The mean HRQOL results in 5 domains were as follows:
PCS score was 39.1 ± 9.5; MCS, 44.6 ± 6.8; symptom/
problem list, 67.6 ± 17.1; effect of disease, 58.5 ± 19.6;
and burden of disease, 41.1 ± 28.4 (Table 1). In PCS,
female, older, less-educated, and jobless patients, with
stroke or diabetes mellitus, reported significantly lower
QOL than the others (p \ 0.05). In symptom/problem list,
patients in PD reported significantly lower QOL than the
others (p \ 0.01), and factors associated with burden of
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disease were the cause of ESRD and the number of
co-existing diseases (p \ 0.05). Serum albumin showed
positive correlation with both PCS and effects of disease
(p \ 0.01). Among all patients, the mean treatment
goal self-efficacy was 3.1 ± 0.6; treatment management
self-efficacy, 3.2 ± 0.6; and treatment satisfaction,
32.7 ± 11.4, respectively (Table 3). Treatment goal self-
efficacy showed positive correlation with PCS, symptom/
problem list, effects of kidney disease, and burden of
kidney disease, whereas treatment management self-effi-
cacy correlated with symptom/problem list and effects of
disease (both p \ 0.05). Treatment satisfaction showed
positive correlation with PCS and effects of disease (both
p \ 0.05).
After adjusting for confounders, both treatment goal
self-efficacy and treatment management self-efficacy sig-
nificantly correlated with all 5 domains, except PCS.
Treatment satisfaction was significantly related with PCS,
MCS, and effects of kidney disease (Table 4).
Discussion
In this study, we measured the HRQOL of dialysis patients,
including both HD and PD. In comparison between PD and
HD patients, we could find significant difference only in
symptom/problem list (i.e., HD patients reported lower
QOL than PD patients). There have been several studies
using KDQOL-36 for evaluating the HRQOL of patients
with chronic kidney disease [25–27], but few studies were
conducted in dialysis patients [28]. Compared to QOL
results from other studies [25, 28], ours were very similar
in PCS, MCS, and Effect of disease. However, some dif-
ferences were observed in the other domains: We report
lower scores in symptom/problem list and higher scores in
burden of disease. Restricting to the HD patients, our
results were also very similar with the results of the Dial-
ysis Outcomes and Practice Patterns Study [27], which was
a prospective, observational, multinational study for HD
patients, using KDQOL-SFTM.
In our study, dialysis patients showed higher scores in
MCS than in PCS, and this has been also reported in sev-
eral previous studies [25–30]. In other words, despite the
worsening of the physical health status, the mental health
of dialysis patients is relatively preserved. This was pre-
viously explained by dynamic adaptation of patients’
expectations to their chronic illness [11, 30].
We also evaluated whether the self-efficacy and treatment
satisfaction, respectively, could impact on the HRQOL of
dialysis patients. In this study, after adjusting for the con-
founders’ effect, self-efficacy on both treatment goal and
treatment management showed significant positive associa-
tion with HRQOL in almost all domains, except PCS.
Oh-Park et al. [22] reported positive association between
self-efficacy and HRQOL in MCS. Therefore, it remains to
be seen whether self-efficacy may influence HRQOL in the
generic and disease-specific domains.
Table 1 Health-related quality of life (HRQOL) scores by general characteristics (unit: mean ± SD)











Male 128 (54.0) 40.3 ± 9.4* 45.3 ± 6.2 68.8 ± 17.2 58.7 ± 19.6 40.3 ± 28.0
Female 109 (46.0) 37.8 ± 9.6 43.9 ± 7.4 66.1 ± 17.0 58.3 ± 19.6 42.1 ± 29.0
Age
\49 years 66 (27.8) 42.3 ± 8.9** 44.1 ± 6.6 67.4 ± 19.5 58.3 ± 19.1 40.7 ± 19.1
50–59 years 59 (24.9) 40.1 ± 10.1 43.9 ± 7.7 69.4 ± 16.3 59.9 ± 20.8 43.6 ± 29.7
60–69 years 62 (26.2) 38.8 ± 9.1 45.4 ± 6.4 68.0 ± 15.2 57.6 ± 20.5 43.3 ± 28.8




52 (21.9) 36.6 ± 9.7** 43.6 ± 7.4 66.0 ± 14.7 60.0 ± 19.3 45.9 ± 31.3
Middle school 50 (21.1) 37.0 ± 10.4 45.7 ± 6.1 63.8 ± 18.2 56.1 ± 22.8 45.0 ± 30.8
High school 80 (33.8) 40.5 ± 8.9 43.9 ± 7.3 68.2 ± 17.8 57.8 ± 18.5 42.0 ± 28.0
College or over 55 (23.2) 41.5 ± 9.5 45.7 ± 6.0 71.6 ± 16.9 60.2 ± 18.5 31.8 ± 21.7
Job
Yes 68 (28.7) 41.9 ± 8.7** 44.3 ± 6.5 70.4 ± 17.6 60.6 ± 18.7 37.6 ± 24.9
No 169 (71.3) 38.0 ± 9.6 44.7 ± 7.0 66.4 ± 16.9 57.6 ± 19.9 42.5 ± 29.7
Total 237 (100.0) 39.1 ± 9.5 44.6 ± 6.8 67.6 ± 17.1 58.5 ± 19.6 41.1 ± 28.4
* p \ 0.05, ** p \ 0.01
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Finally, treatment satisfaction was positively associated
with HRQOL in PCS, MCS, and effects of disease. These
associations are supported by Callahan’s study [23],
reporting that patients’ participation in care planning could
lead to increased treatment satisfaction and increased
HRQOL scores. This implies that high treatment satisfac-
tion can improve patients’ compliance and control disease
more effectively, consequently leading to better HRQOL
and decrease mortality rate.
Our study has several limitations. First, our participants
were volunteer outpatients recruited in two university
hospitals; therefore, they had some difference with the
general dialysis patients especially in their socio-economic
characters and disease severity, and these differences might
Table 2 HRQOL scores by disease-specific characteristics (unit: mean ± SD or Pearson’s correlation coefficient)











HD 172 (72.6) 39.3 ± 9.7 44.6 ± 7.0 69.6 ± 16.6** 59.5 ± 19.4 39.9 ± 27.7
PD 65 (27.4) 38.7 ± 9.0 44.8 ± 6.4 62.1 ± 17.5 55.9 ± 20.0 44.3 ± 30.1
Dialysis duration
\2 years 93 (39.4) 40.0 ± 9.7 44.0 ± 6.7 69.5 ± 16.7 58.6 ± 19.6 40.9 ± 28.3
2–5 years 82 (34.7) 39.0 ± 9.6 45.0 ± 7.1 68.0 ± 17.5 59.3 ± 19.9 43.0 ± 29.6
[5 years 62 (26.3) 38.0 ± 9.1 45.1 ± 6.7 64.0 ± 16.6 57.3 ± 19.5 39.1 ± 27.3
Cause of ESRD
Hypertension 69 (29.1) 38.2 ± 9.8 45.4 ± 6.0 70.6 ± 14.9 61.5 ± 18.9 52.5 ± 32.9**
Diabetes 94 (39.7) 39.0 ± 9.1 45.5 ± 7.5 65.2 ± 17.7 57.7 ± 20.3 34.7 ± 24.1
Glomerulonephritis 25 (10.5) 42.6 ± 11.3 42.4 ± 7.7 73.2 ± 18.1 59.5 ± 18.8 48.2 ± 29.9
Others 49 (20.7) 38.9 ± 8.8 43.0 ± 5.6 65.1 ± 17.6 55.2 ± 19.6 43.7 ± 22.7
Dialysis adequacy
Adequate 171 (72.2) 38.6 ± 9.6 44.4 ± 7.0 68.0 ± 17.4 57.4 ± 20.0 41.1 ± 29.5
Inadequate 39 (27.8) 40.4 ± 9.3 45.3 ± 6.5 66.4 ± 16.5 61.4 ± 18.4 41.1 ± 25.5
Co-existence of AMI
Yes 5 (2.1) 37.6 ± 5.4 50.0 ± 3.4 63.3 ± 18.2 45.6 ± 18.0 41.2 ± 29.2
No 232 (97.9) 39.2 ± 9.6 44.5 ± 6.8 67.3 ± 17.1 58.8 ± 19.6 41.1 ± 28.5
Co-existence of Stroke
Yes 22 (9.3) 33.1 ± 9.5** 46.7 ± 5.8 62.9 ± 16.2 57.2 ± 18.5 52.6 ± 32.4
No 215 (90.7) 39.7 ± 9.4 44.4 ± 6.9 68.0 ± 17.2 58.6 ± 19.7 39.9 ± 27.8
Co-existence of HTN
Yes 199 (84.0) 38.8 ± 9.3 44.6 ± 6.8 67.4 ± 16.6 57.1 ± 18.7 42.2 ± 28.3
No 38 (16.0) 40.7 ± 10.7 44.5 ± 6.6 68.4 ± 19.8 65.9 ± 22.7 35.2 ± 28.5
Co-existence of IHD
Yes 16 (6.8) 37.2 ± 9.4 47.7 ± 5.7 71.5 ± 10.8 65.4 ± 17.9 57.4 ± 28.3
No 221 (93.2) 39.3 ± 9.4 44.4 ± 6.9 67.3 ± 17.5 58.0 ± 19.6 39.9 ± 28.1
Co-existence of DM
Yes 119 (50.2) 36.8 ± 8.8** 45.3 ± 6.1 67.1 ± 15.6 56.9 ± 19.4 43.6 ± 30.7
No 118 (49.8) 41.5 ± 9.7 44.0 ± 7.4 68.0 ± 18.7 60.1 ± 19.7 38.6 ± 25.8
Number of co-existing disease
None 25 (10.5) 41.9 ± 10.9** 45.5 ± 6.7 70.8 ± 18.9 61.1 ± 22.0 37.7 ± 26.2**
1 Disease 92 (38.8) 41.7 ± 9.3 43.0 ± 7.6 68.1 ± 18.9 60.1 ± 20.0 39.1 ± 27.3
2 Diseases 96 (40.5) 37.2 ± 8.5 45.3 ± 6.1 66.0 ± 15.9 55.1 ± 18.4 38.0 ± 27.9
?3 Diseases 24 (10.1) 34.0 ± 9.3 47.4 ± 5.6 68.2 ± 12.4 59.0 ± 18.6 64.6 ± 27.9
Serum albumin
levela
3.76 ± 0.46a 0.221** -0.097 0.220** 0.052 -0.123
Total 237 (100.0) 39.1 ± 9.5 44.6 ± 6.8 67.6 ± 17.1 58.5 ± 19.6 41.1 ± 28.4
* p \ 0.05, ** p \ 0.01
a Serum albumin level was expressed as ‘‘mean ± SD’’ and its association with HRQOL was analyzed by Pearson’s correlation coefficient
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modified their perception of QOL. Therefore, our results
must be applied to general dialysis patients with caution.
Second, the instruments, the Korean version of KDQOL-
36, self-efficacy and treatment satisfaction questionnaires
that we used have not been validated yet.
In spite of those limitations, to the best of our knowl-
edge, this is the first study to use KDQOL-36 for evaluating
HRQOL of dialysis patients and to investigate the impact
of self-efficacy and treatment satisfaction on HRQOL in
Korea.
This study has main findings. First, regular and sys-
tematic monitoring for dialysis patients’ HRQOL must be
considered as an effective tool of quality control in dialysis
care in Korea. Secondly, self-efficacy and treatment satis-
faction independently influenced HRQOL in almost all
domains. Therefore, interventions to increase self-efficacy
and treatment satisfaction should be considered in caring
for patients with ESRD.
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